Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-063-5 | CAS number: 30125-47-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 3,3'-(1,4-phenylenediimino)bis[4,5,6,7-tetrachloro-1H-isoindol-1-one]
- EC Number:
- 226-999-5
- EC Name:
- 3,3'-(1,4-phenylenediimino)bis[4,5,6,7-tetrachloro-1H-isoindol-1-one]
- Cas Number:
- 5590-18-1
- Molecular formula:
- C22H6Cl8N4O2
- IUPAC Name:
- 3,3'-(1,4-phenylenediimino)bis(4,5,6,7-tetrachloro-1H-isoindol-1-one)
- Reference substance name:
- mono/bis-methoxy derivatives
- Molecular formula:
- C22-24H6-12Cl6-8N4O2-4
- IUPAC Name:
- mono/bis-methoxy derivatives
- Test material form:
- solid: bulk
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- - Physical state: Solid, orange
- Analytical purity: 97.8%
- Lot/batch No.: 13277HM8
- Storage condition of test material: Room temperature
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Germany GmbH
- Age at study initiation: 5 – 8 weeks
- Mean weight at study initiation: 29.5 g
- Assigned to test groups randomly: yes, under following basis: appropriate computer program
- Housing: Makrolon cages, type M II; single housing
- Diet (e.g. ad libitum): Standardized pelleted feed (Maus/Ratte Haltung "GLP", Provimi Kliba SA, Kaiseraugst, Switzerland) ad libitum
- Water (e.g. ad libitum): Drinking water from bottles was available ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: Using the vehicle corn oil a homogeneous suspension of the test substance was obtained. Therefore, corn oil was used as vehicle, which has been demonstrated to be suitable in the in vivo Micronucleus test and for which historical control data are available.
- Concentration of test material in vehicle: 50, 100 or 200 mg/mL
- Amount of vehicle (if gavage or dermal): 10 mL - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
To achieve the homogeneity of the test substance in the vehicle, the test substance preparation was stirred with a spatula and shaken thoroughly. All test substance formulations were prepared immediately before administration. - Duration of treatment / exposure:
- 24 or 48 hrs
- Frequency of treatment:
- once
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day
- Remarks:
- Basis:
analytical conc.
Depending on the dose, about 88% - 104% of the theoretical values were determined analytically. Only the recovery rate of the low dose group (88%) was slightly lower than expected (90 - 110%).
- Dose / conc.:
- 1 000 mg/kg bw/day
- Remarks:
- Basis:
analytical conc.
Depending on the dose, about 88% - 104% of the theoretical values were determined analytically. Only the recovery rate of the low dose group (88%) was slightly lower than expected (90 - 110%).
- Dose / conc.:
- 2 000 mg/kg bw/day
- Remarks:
- Basis:
analytical conc.
Depending on the dose, about 88% - 104% of the theoretical values were determined analytically. Only the recovery rate of the low dose group (88%) was slightly lower than expected (90 - 110%).
- No. of animals per sex per dose:
- 5 males per treatment
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- The positive controls, both dissolved in deionised water, were administered to male animals once orally (cyclophosphamide, CPP) or intraperitoneally (vincristine sulphate, VCR) each in a volume of 10 mL/kg body weight. The animals were sacrificed after 24 hours.
Examinations
- Tissues and cell types examined:
- The bone marrow was prepared according to the method described by Schmid (1976, 1977) and Salamone et al. (1980).
- The animals were anesthetized with isoflurane and afterwards sacrificed by cervical dislocation. Then the two femora were prepared by dissection and removing all soft tissues.
- After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with foetal calf serum (FCS) which was preheated up to 37°C (about 2 mL/femur).
- The suspension was mixed thoroughly with a pipette and centrifuged at 300 x g for 5 minutes. The supernatant was removed and the precipitate was resuspended in about 50 μL fresh FCS.
- One drop of this suspension was dropped onto clean microscopic slides, using a Pasteur pipette. Smears were prepared using slides with ground edges. The preparations were dried in the air and subsequently stained. - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: In a pretest for the determination of the acute oral toxicity, 2 000 mg/kg body weight recommended as the highest dose according to the OECD Guideline was tolerated by all animals (male and female) without clinical signs of toxicity. Additionally, discoloured faeces were observed from 4 hours after test substance administration until sacrifice of the animals.
On account of the results of the pretest, 2 000 mg/kg body weight was selected as the highest dose in the present cytogenetic study. 1 000 mg/kg and 500 mg/kg body weight were administered as further doses.
TREATMENT AND SAMPLING TIMES:
sacrifice interval 24 h
vehicle control, 500 mg/kg bw TS, 1000 mg/kg bw TS, 2000 mg/kg bw TS, 20 mg/kg bw CPP, 0.15 mg/kg bw VCR
sacrifice interval 48 h
vehicle control, 2000 mg/kg bw TS
DETAILS OF SLIDE PREPARATION:
- The slides were stained with eosin and methylene blue (modified May-Grünwald solution or Wrights solution) for about 5 minutes.
- After briefly rinsing in deionised water, the preparations were soaked in deionised water for about 2 - 3 minutes.
- Subsequently, the slides were stained with Giemsa solution (15 mL Giemsa plus 185 mL deionised water) for about 15 minutes.
- After rinsing twice in deionised water and clarifying in xylene, the preparations were mounted in Corbit-Balsam. - Evaluation criteria:
- A finding is considered positive if the following criteria are met:
• Statistically significant and dose-related increase in the number of PCEs containing micronuclei.
• The number of PCEs containing micronuclei has to exceed both the concurrent vehicle control value and the range of the historical vehicle control data.
A test substance is considered negative if the following criteria are met:
• The number of cells containing micronuclei in the dose groups is not statistically significant increased above the concurrent vehicle control value and is within the range of the historical vehicle control data. - Statistics:
- The asymptotic U test according to MANN-WHITNEY (modified rank test according to WILCOXON) was carried out to clarify the question whether there are statistically significant differences between the untreated control group and the treated dose groups with regard to the micronucleus rate in polychromatic erythrocytes. The relative frequencies of cells containing micronuclei of each animal were used as a criterion for the rank determination for the U test. Statistical significances were identified as follows:
* p ≤ 0.05
** p ≤ 0.01
However, both biological relevance and statistical significance were considered together.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The single oral administration of the vehicle corn oil in a volume of 10 mL/kg body weight led to 1.5‰ polychromatic erythrocytes containing micronuclei after the 24-hour sacrifice interval or to 1.6‰ after the 48-hour sacrifice interval, respectively.
After the single administration of the highest dose of 2 000 mg/kg body weight, 1.9‰ polychromatic erythrocytes containing micronuclei were found after 24 hours and 1.5‰ after 48 hours.
In the two lower dose groups, rates of micronuclei of 1.1‰ (1 000 mg/kg group) and 2.1‰ (500 mg/kg group) were detected after a sacrifice interval of 24 hours in each case.
The positive control substance for clastogenicity, cyclophosphamide, led to a statistically significant increase (23.2‰) in the number of polychromatic erythrocytes containing exclusively small micronuclei, as expected.
Vincristine sulphate, a spindle poison, produced a statistically significant increase (45.0‰) in the number of polychromatic erythrocytes containing micronuclei. A significant portion increase, 13.0‰ was attributable to large micronuclei.
The number of normochromatic erythrocytes containing micronuclei did not differ to any appreciable extent in the vehicle control group or in the various dose groups at any of the sacrifice intervals.
No dose-dependent inhibition of erythropoiesis induced by the treatment of mice with the test substance was detected. The ratio of polychromatic to normochromatic erythrocytes was in the range of the vehicle control values in all dose groups.
Any other information on results incl. tables
Table 1: Induction of Micronuclei in bone marrow cells
Test group | Sacrifice interval [hrs] | Animal No. | Micronuclei in PCE | Number of NCE ( c) | |
total (a) [‰] | large (b) [‰] | ||||
Vehicle control: | |||||
corn oil | 24 | 5 | 1.5 | 0.0 | 3914 |
Test substance | |||||
500 mg/kg bw. | 24 | 5 | 2.1 | 0.1 | 4532 |
Test substance | |||||
1 000 mg/kg bw. | 24 | 5 | 1.1 | 0.0 | 5094 |
Test substance | |||||
2 000 mg/kg bw. | 24 | 5 | 1.9 | 0.0 | 4177 |
Positive control | |||||
cyclophosphamide | |||||
20 mg/kg bw. | 24 | 5 | 23.2** | 0.0 | 4778 |
Positive control | |||||
vincristine sulfate | |||||
0.15 mg/kg bw. | 24 | 5 | 45.0** | 13.0** | 4304 |
Vehicle control | |||||
corn oil | 48 | 5 | 1.6 | 0.0 | 4141 |
Test substance | |||||
2 000 mg/kg bw. | 48 | 5 | 1.5 | 0.0 | 4033 |
PCE = polychromatic erythrocytes | |||||
NCE = normochromatic erythrocytes | |||||
bw. = body weight | |||||
a = sum of small and large micronuclei | |||||
b = large micronuclei (indication for spindle poison effect) | |||||
c = number of NCEs observed when scoring 10 000 PCEs | |||||
* = p ≤ 0.05 | |||||
** = p ≤ 0.01 |
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions chosen here, the test substance has no chromosome-damaging (clastogenic) effect nor does it lead to any impairment of chromosome distribution in the course of mitosis (aneugenic activity) in bone marrow cells of NMRI mice in vivo.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.